Patents by Inventor Ernesto De Jesús Alcañiz

Ernesto De Jesús Alcañiz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carbosilane dendrimers, preparation method thereof and use of same
    Patent number: 8603493
    Abstract: Novel carbosilane dendrimers, their preparation and their uses. The dendrimers of the invention have secondary, tertiary and quaternary amino groups at their branch ends. Their possible uses include vehicles for carrying anionic-charged molecules in the blood, such as nucleic acids, among them ODN and RNAi, and other anionic drugs with which they have the capacity of interacting, protecting them from interaction with plasma protein and/or increasing their penetration rate in target cells. In the cases where the bond is long-lasting, the dendrimers of the invention can be used to fix anionic molecules to surfaces. Their uses also include their administration as active ingredients to prevent or treat diseases caused by micro-organisms with whose structure and/or life cycle they interfere.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: December 10, 2013
    Assignee: Dendrico, S.L.
    Inventors: Francisco De La Mata De La Mata, Rafael Gómez Ramírez, Juan Carlos Flores Serrano, Ernesto De Jesús Alcañiz, Paula Ortega López, Ma Ángeles Muñoz Fernández, Jesús Francisco Bermejo Martin, Ma Jesus Serramía Lobera, Gerónimo Fernández Gómez-Chacón, Louis Chonco Jiménez, Maria Isabel Clemente Mayoral, José Luis Jiménez Fuentes
  • Novel carbosilane dendrimers, preparation method thereof and use of same
    Publication number: 20100034789
    Abstract: Novel carbosilane dendrimers, their preparation and their uses. The dendrimers of the invention have secondary, tertiary and quaternary amino groups at their branch ends. Their possible uses include vehicles for carrying anionic-charged molecules in the blood, such as nucleic acids, among them ODN and RNAi, and other anionic drugs with which they have the capacity of interacting, protecting them from interaction with plasma protein and/or increasing their penetration rate in target cells. In the cases where the bond is long-lasting, the dendrimers of the invention can be used to fix anionic molecules to surfaces. Their uses also include their administration as active ingredients to prevent or treat diseases caused by micro-organisms with whose structure and/or life cycle they interfere.
    Type: Application
    Filed: July 21, 2006
    Publication date: February 11, 2010
    Inventors: Francisco De La Mata De La Mata, Rafael Gomez Ramirez, Juan Carlos Flores Serrano, Ernesto De jesus Alcaniz, Paula Ortega Lopez, Ma Angeles Munoz Fernandez, Jesus Francisco Bermejo Martin, Gerónimo Fernandez Gomez-Chacon, Ma Jesús Serramia Lobera, Louis Chonco-Jimenez, Maria Isabel Clemente Mayoral, José Luis Jimenez Fuentes